We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Failure of Mutant Menin Protein to Block Hedgehog Signaling Triggers a Type of Endocrine Cancer

By LabMedica International staff writers
Posted on 09 May 2013
Mutations in the gene that encodes the protein menin cause a hereditary cancer syndrome called MEN1 (multiple endocrine neoplasia type 1) due to the inability of the mutant menin protein to block the oncogenic effects of enhanced Hedgehog signaling.

The Hedgehog signaling pathway transmits information to embryonic cells required for proper development. More...
Different parts of the embryo have different concentrations of Hedgehog signaling proteins. The pathway takes its name from its polypeptide ligand, an intercellular signaling molecule called Hedgehog (Hh) found in fruit flies of the genus Drosophila. Hh is one of Drosophila's segment polarity-gene products, involved in establishing the basis of the fly body plan. The molecule remains important during later stages of embryogenesis and metamorphosis, and diseases associated with the malfunction of this pathway include basal cell carcinoma.

Individuals with MEN1 are at a substantially increased risk of developing neuroendocrine tumors, including cancer of the pancreatic islet cells that secrete insulin.

Investigators at the University of Pennsylvania (Philadelphia, USA) performed DNA microarray analysis studies on murine pancreatic islets with mutated menin genes. They reported in the April 15, 2013, online edition of the journal Cancer Research that elimination of menin enhanced pro-proliferative and oncogenic Hedgehog signaling activity.

The investigators showed that menin functioned by physically interacting with a second protein, PRMT5 (protein arginine methyltransferase 5). The menin-PRMT5 complex bound to the promoter of the Gas1 (growth arrest-specific protein 1) gene, where PRMT5 functioned as an epigenetic inhibitor by methylating histone proteins, which inhibited gene transcription. The Gas1 protein normally promoted Hedgehog signaling, and thus by inhibiting Gas1 expression, menin and PRMT5 effectively blocked the pathway's ability to induce cell proliferation. In MEN1 cells mutant menin failed to bind to PRMT5, and Gas1 continued to enhance Hedgehog signaling.

In another set of experiments the investigators treated a mouse model of human MEN1 syndrome with the Hedgehog pathway inhibitor Erivedge, a drug approved by the [US] Food and Drugs Administration for the treatment of metastatic or locally advanced basal cell carcinoma. They reported that the drug reduced proliferation of tumor cells and lowered blood insulin levels.

"Because we show in this mouse tumor model that we can significantly suppress proliferation of tumor cells in pancreatic islets and that we can reduce the higher insulin levels with a drug, which was just clinically approved to be safe, that naturally raises the question of whether, in patients who have mutation in this gene or enhanced Hedgehog signaling, this drug can improve patient symptoms to reduce tumor progression or insulinemia," said senior author Dr Xianxin Hua, associate professor of cancer biology at the University of Pennsylvania.

Related Links:

University of Pennsylvania



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.